{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "165 patients scheduled for VRS were randomly assigned"
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 2,
        "evidence": "AoA-guided GA combined with IPA at a single dose of 1 g of paracetamol (acetaminophen) or 2.5 g of metamizole or both"
      },
      "Objective": {
        "score": 1,
        "evidence": "we assessed the impact of preemptive analgesia with COX-3 inhibitors"
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "impact of preemptive analgesia with COX-3 inhibitors, administered alongside GA with AoA-guided IROA, on the incidence of PONV, oculocardiac reflex (OCR), and oculoemetic reflex (OER)"
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "patients scheduled for VRS were randomly assigned"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "165 patients scheduled for VRS were randomly assigned"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "153 analyzed patients undergoing VRS"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "PONV in 4%, OCR in 10%, and OER in 0% of the 153 analyzed patients"
      },
      "Harms": {
        "score": 1,
        "evidence": "PONV was observed in 2.11% (3/142) of patients"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 11,
    "max_score": 25
  },
  "model": "gpt-4o"
}